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Alzheimer’s disease, a debilitating neurodegenerative illness, is caused by the irreversible 
aggregation of beta-amyloid proteins in the brain. In Alzheimer’s brains, the protein can become 
disfigured, causing it to aggregate into long, insoluble fibers that deposit on brain tissue. 
Studying the aggregation mechanisms of amyloid proteins can lead to a deeper understanding of 
the progression of Alzheimer’s disease and possibly point towards a potential cure or treatment 
for the disease. Heat induced aggregation of insulin provides a model system to study the 
aggregation of amyloidogenic proteins. This study investigates the early stages of heat induced 
insulin aggregation using dynamic light scattering in order to assess the aggregation mechanism 
and the potential for reversal by thermal quenching to room temperature. In order to accomplish 
this, samples of insulin solution were heated for specific incubation intervals and monitored 
using dynamic light scattering in the time after removal from heat to study the behavior of 
insulin after quenching to room temperature. Results indicate that large protein aggregates form 
after sufficient time at heat, but quenching to room temperature can cause them to dissociate. 
However, the initial stage in the aggregation mechanism is shown to be an irreversible 
transformation from monomer to dimer. 
 
 




Alzheimer’s disease is an irreversible neurodegenerative disease that slowly attacks 
memory and degrades brain function (1). The disease affects primarily older patients and is the 
most common cause of dementia among older people (1). According to the Alzheimer’s 
Association, one in eight older Americans – a population totaling 5.4 million - are living with 
Alzheimer’s disease (2). It is the sixth-leading cause of death in the United States (2). Some 
medications can help lessen symptoms such as memory loss and confusion, but unlike the other 
top ten causes of death in the United States, there is currently no way to cure, prevent, or slow 
the progression of Alzheimer’s disease (3) (4). Thus, there is an urgent need to understand the 
cause of and find a cure for Alzheimer’s disease. 
The appearance of long, insoluble protein deposits on brain tissue is a common 
characteristic of many neurodegenerative diseases, including Alzheimer’s disease (5). The 
deposits, called plaques and tangles, are found between and around neurons in Alzheimer’s 
disease patients’ brains (2). These buildups are made up of beta-amyloid proteins that are 
produced from amyloid precursor protein (APP) in the fatty membrane surrounding nerve cells (6) 
(7). APP can be found in healthy brains as a precursor for other proteins that promote neuronal 
growth and survival. However, by an alternative pathway, APP forms beta-amyloid peptides that 
become disfigured, causing the formation of fibril aggregates with other beta-amyloid peptides. 
It is presumed that specific sizes of beta-amyloid aggregates in block cell communication and 
disrupt processes that normal cells need to survive (2). It has been shown that mice injected with 
beta-amyloid fibril “building blocks” develop symptoms characteristic of Alzheimer’s disease (8). 
The continued growth of these smaller aggregates leads to the production of plaques on brain 
tissue (7). In order to prevent or cure Alzheimer’s disease, it is important to understand the 
aggregation mechanism and the potential for aggregation-reversal of the beta-amyloid peptide. 
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Historically, much work has been performed on the properties and aggregation of 
amyloid proteins, including the beta-amyloid peptide. It is currently believed that the aggregation 
of beta-amyloids is caused by a partial unfolding of the protein. The protein undergoes a coil-to-
β-sheet transition and subsequently self-associates due in part to the exposure of hydrophobic 
regions within the tertiary structure. It is believed that the subsequently formed oligomers and 
protofibrils are the building blocks for mature, insoluble fibrils (6).  
It has been found that amyloid proteins exhibit similar aggregation behaviors that can be 
caused by a number of factors such as pH and elevated solution temperature. These two in 
particular have been the classical methods of inducing amyloid aggregation (9). Human insulin, 
for example, is a classic amyloidogenic protein that aggregates at high temperature (> 60ºC) in 
acidic solution (pH = 1.6). After sufficient exposure to high temperatures, insulin in acidic 
solution will form long, insoluble fibers. The absorbance intensity of aggregating insulin exhibits 
a sigmoidal curve, increasing as aggregation progresses. Initially, the intensity increase is slow, 
but this is followed by a rapid increase as the insulin aggregates into fibrils. After this rapid fibril 
formation, the growth saturates, and the rate of intensity increase becomes zero. Many studies 
have shown that protein fibers eventually form at the end of the annealing process (9). It is known 
that the formation of amyloid protein fibers is irreversible, although it is unclear at what point 
irreversibility is attained. Since insulin is relatively inexpensive, readily available, and exhibits a 
similar molecular and fibril structure to beta-amyloids, it is an ideal model system to study beta-
amyloid aggregation (10) (11) (12). By studying the amyloid aggregation in this model system we can 
gain a better understanding of the cause of – and a possible mechanism to inhibit or cure – the 
underlying causes of Alzheimer’s disease.  
Insulin heat precipitation does not significantly alter the natural structure of the 
molecules, thus making it an ideal way to analyze the aggregation process. The aggregation itself 
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is a process understood to be comprised of three reactions. The first is nucleation, the slowest of 
the three, involving the simultaneous interaction of three to four insulin monomers. The second 
reaction is the growth of the nucleus into fibrils and the third is the formation of large precipitate 
groups. The large precipitate groups are generally irreversibly insoluble without major changes 
in solution characteristics (9). A proposed mechanism of insulin fibrillation is diagramed in Figure 
1, though the actual mechanism is still under investigation (10). 
 
Figure 1: A proposed mechanism of insulin aggregation (10). 
 
Preliminary kinetic studies using dynamic light scattering (DLS) were performed on 
insulin in acidic solution (pH = 1.6) at 2 mg/ml. It is known that the scattering intensity is 
proportional to the size of the aggregates at a constant concentration. Figure 2 shows the 
scattering intensity variation (scattering angle = 90º) of insulin aggregation at 60ºC as a function 
of annealing time. As previously mentioned the data follows a sigmoidal curve, though only the 
initial portion is shown. The early stage (< 140 min) of the aggregation indicated an incremental 
increase in scattering intensity. A sudden increase in scattering intensity was observed after 
approximately 150 minutes and beyond this point the average scattering intensity fluctuates 
drastically due to many intensity spikes recorded over the data collection time, indicative of the 
formation of large and non-uniform aggregates. These results point towards an early aggregation 





Figure 2: (a) The scattering intensity at 90° of human insulin at 60°C as a function of annealing time. For better 
resolution, the enlarged plot of the early stage aggregation of the insulin (in red box) is shown in (b). 
 
 Figure 2 makes apparent the initially-slow heat induced aggregation of insulin. This study 
assumes that irreversibility by thermal quenching – removal from heat to a room temperature 
environment – is attained very early in the aggregation process, before fibrils are formed and 
insulin aggregates become insoluble. Thus, the area of interest on the sigmoidal curve is early, 
before rapid aggregation begins. The earliest portion of this slow stage will be investigated to 
assess the potential reversibility of aggregation by thermal quenching. It is hypothesized that 
irreversibility is attained at heating times between 10 and 20 minutes. The goal of this study is to 
find that point of irreversibility and show that before that point is reached, reversal of insulin 

































































Human insulin was provided by Professor Georges Belford and his group at Rensselaer 
Polytechnic Institute. All reagents and chemicals are analytical grade. 
 
Sample Preparation 
Solutions of human insulin in concentrations of 20 mg/ml are made by dissolving 40 mg 
insulin in 2 ml of a previously prepared “insulin solvent” of 100 mM NaCl and 25 mM HCl of 
pH 1.6. The solutions are titrated to basicity with 1M NaOH. Insulin is not soluble near its pI of 
5.6 and comes out of solution. NaOH addition is stopped once the solution becomes sufficiently 
basic for the insulin to redissolve. The solutions are then back-titrated using the insulin solvent, 
again just past the point of insulin redissolution. After titration, two solutions (up until this point 
prepared in parallel) are combined, diluted to 8 mg/ml using the insulin solvent, and adjusted to a 
pH of 1.6 with 1M HCl using a Thermo brand pH meter. Dust and large particle contaminants 
are removed by filtering the solutions through 0.2 μm hydrophilic filters at multiple stages of the 
process, including before the sample pH cycle titrations and after the pH adjustment to 1.6. The 
samples are divided into light scattering cuvettes, with approximately 1 ml of insulin solution in 
each. The cuvettes are sealed and the samples are checked for uniformity of size (~2.2 nm 
hydrodynamic radius for monomeric insulin) using dynamic light scattering. The samples are 






Aggregation is induced by placing the glass cuvettes into a dry heat block, set on Low, 
Power Level 9 for a measured temperature of 65˚C. The amount of time required for a 1 ml 
sample in a glass DLS cuvette to reach 65˚C, the incubation temperature, is dependent on the 
sample position in the heat block. A temperature map of the heat block was created, shown in 
Figure 3. The well that was selected for use is marked by an asterisk. In this well, approximately 
seven minutes are required for the sample to reach the incubation temperature. 
The samples are allowed this warm up time to reach 65˚C and then further incubated for 
set intervals of time. An example heating schedule is shown in Figure 4, where the sample is 
warmed, incubated, and removed from heat. Immediately after removal from heat, the samples 
are measured by DLS. This entire process is performed on one sample at a time in order to 
ensure uniformity in heating and measurement.  
 
Figure 3: Heat block map. (a) Thermometer well. (b) Sample well. The well used for sample heating is denoted by 




Figure 4: Example sample heating history. The red diamonds indicate DLS measurements (initial measurement not 
shown). The dotted black line represents unknown temperature decrease back to room temperature. 
 
Dynamic Light Scattering 
The quality of prepared insulin samples and the assessment of their aggregation is 
performed using dynamic light scattering (DLS). DLS is a powerful analytical method for 
determining the hydrodynamic radius of particles in solution. The instrument itself is an ALV 
Compact Goniometer System (CGS-3MD), consisting of a 22mW He-Ne laser that emits 
vertically polarized light at a wavelength of 632.8 nm and four avalanche photo diode (APD) 
detectors that collect the intensity of the scattered light (13) (14). For this study, single detector 
mode was used with a scattering angle (θ) of 90°.  
When the laser light hits particles in solution, it scatters in all directions due to Rayleigh 
scattering. Because the laser is monochromatic and coherent, the detector observes a time-
dependent fluctuation in intensity due to the Brownian motion of the particles in solution. This 
variable intensity is collected by the detectors and an autocorrelation function is generated to 
relate the delay time, τ and scattering intensity, I. The autocorrelation function is generated by an 
ALV-7004 digital multiple tau real time correlator and expressed as Equation 1. 
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𝐺(𝜏) = ∫ 𝐼(𝑡)𝐼(𝑡 + 𝜏)𝑑𝑡
∞
0
    (Equation 1) 
In Equation 2, time delay, τ, refers to an arbitrary amount of time after the intensity 
measurement was taken (time = t). As τ grows larger, G(τ) exhibits an exponential decay as the 
correlation between the initial state and final state scattering intensities deteriorates. This 
relationship preserves the dynamic information of the particles in solution. Additionally, it has 
the ability to reflect system polydispersity, because populations of different sizes exhibit 
different decay times. Multiple decays can be shown within one autocorrelation function. Further 
experimental conditions are considered in a relationship expressing G(τ) in terms of the field 
autocorrelation function, g(τ), generated from the Siegert relation. 
𝐺(𝜏) = 1 + 𝛾𝑔(𝜏)2     (Equation 2) 
Here, γ is the instrumental coherence factor. The field autocorrelation function, g(τ), 
represents the time decay of the position autocorrelation function of the particles. For a 
polydisperse system, g(τ) can be expressed as follows. 
𝑔(𝜏) = ∑ 𝐴𝑖𝑒
−𝐷𝑖𝑞
2𝜏







     (Equation 4) 
In this expression, q is the scattering vector and Ai represents the light scattering 
amplitude of the particle i with diffusion coefficient Di 
(14). For solutions made up of spherical, 
non-interacting particles undergoing Brownian motion, the Stokes-Einstein equation relates the 




     (Equation 5) 
Here, k, T, and ηw are the Boltzmann constant, absolute temperature, and the viscosity, 
respectively. In this case, the viscosity is that of water (the solvent). The geometry of aggregating 
insulin is not spherical, so Ri is replaced in Eq. 1 by RHi, an equivalent hydrodynamic radius. 
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Thus, the size of particles in solution is obtained. The ALV software analyzes the generated 
autocorrelation function using CONTIN procedure. The algorithm is ideal for polydisperse and 
multimodal systems – for instance, a solution of aggregating insulin with particle populations of 
different sizes (15) (16).  
The insulin samples are analyzed with DLS before and after heating, allowing for 
detailed analysis of particles in the solution. Three to five measurements at room temperature 
lasting 60 seconds each are taken immediately after the samples are removed from heat. Identical 
sets of measurements are repeated again 30 and/or 60 minutes after removal from heat, once the 
samples have been allowed to rest at room temperature, and additionally 24+ hours after heating. 
The scattering intensity, autocorrelation function, and particle size distribution data are collected 
and analyzed over all measurement points in order to observe the insulin aggregation after 
removal from heat. 
 
Data Analysis 
 The ALV700X software outputs data in multiple forms. Most of this data is interpretable 
as produced, but some, namely the size distribution data of the particles in solution, needs 
additional work in order to generate quantifiable figures. Custom MATLAB code was written in 
order to analyze this data. The code intakes Excel files filled with peak distribution data points. 
Iterating over data sets for all measured samples, it calculates peak width by identifying the 
maximum point on the distribution peak (which is equal to, by definition, 1) and then the 
derivative as it moves to the next point on left of the peak. It repeats this process until the 
derivative is null, at which point the program has reached the left boundary of the peak. This 
point is saved, the process is repeated to the right of the peak. The difference of the two saved 
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points is calculated as the peak width. The program records all data back into the Excel sheet 





Results and Discussion 
 As described previously, ALV700X software produces data in the forms of the measured 
scattering intensity, the generated autocorrelation function, and the hydrodynamic radius 
distribution. A preliminary study, different from the one proposed in the Sample Heating section, 
was carried out before the development of the aforementioned procedure using identical insulin 
samples. The details and results of this study and the formal procedure are described below. 
 
Preliminary results 
Initial studies on solutions of insulin revealed the possibility of reversal by thermal 
quenching. Samples of insulin were heated for increments of 5 minutes, allowed to equilibrate to 
room temperature, and monitored with DLS. The most telling result of this preliminary study 
was the measured scattering intensity, which is proportional to the particle size when the 
concentration remains constant.  
 
Figure 5: Insulin scattering intensity measurements taken after (a) one, and (b) two 5-minute heating periods 


























































After one 5-minute increment of heating and equilibration to room temperature, the 
average scattering intensity was equal to that of the initial measurement at 35 kHz. No intensity 
change was realized. After two 5-minute heating increments, totaling 10 minutes of heating, a 
slight increase in average scattering intensity was realized, but no substantial change was 
present. The results are visible in Figure 5, which shows the intensity measurements versus the 
measurement time.  
However, after three 5-minute heating increments, a new phenomenon was realized. 
After equilibration to room temperature, the first measurements taken with DLS showed spikes 
in intensity. Intensity spikes are indicative of large particles diffusing into and out of the laser 
light. Because the solutions are sealed, these large particles must be formations of insulin 
aggregates. However, these spikes were not repeated in subsequent measurements. Figure 6 
shows two of the measurements taken after three 5-minute heating periods. 
 
Figure 6: Insulin scattering intensity measurements taken after three 5-minute heating increments, totaling 15 
minutes at heat. The blue line is first measurement taken after equilibration to room temperature. 
 
The phenomenon witnessed in Figure 5 was repeated after heating for an additional 5-minute 






























temperature, even more intensity spikes were present. Again, these spikes decay into a relatively 
flat intensity baseline. Figure 7 shows the measurements taken after four 5-minute heating 
periods. 
 
Figure 7: Insulin scattering intensity measurements taken after four 5-minute heating increments, totaling 20 
minutes at heat. The blue line is first measurement taken after equilibration to room temperature; red, the second, 
and green, later. 
 
The presence of intensity spikes is indicative of large particles forming in solution after 
heating. These aggregates dissociate after time spent at room temperature. However, it is 
important to note that the intensity baseline that is realized in Figures 6 and 7 is not equal to the 
initial intensity baseline of 35 kHz; it is slightly higher (around 38 kHz after 20 minutes at heat). 
Although the large particles that cause the intensity spikes are disappearing, some permanent 
aggregation is present.  
 
Study results 
The preliminary study showed that the larger aggregates formed after heating will 
dissociate after thermal quenching to room temperature. The study described in the Sample 






























assess the reversibility of aggregation induced with shorter heating times. Based on the 
aforementioned preliminary results, identical solutions of insulin were heated for 10, 15, 25, and 
29 minutes in order to assess even earlier stages in the aggregation process. The autocorrelation 
functions, hydrodynamic radius peak distributions and widths, and scattering intensity 
measurements for those samples are discussed below. 
The autocorrelation functions for the heated samples are shown below in Figure 8. They 
show the average autocorrelation functions generated at specified times after the samples are 
removed from heat. The autocorrelation function, as discussed earlier, represents the decay in 
signal as lag time grows. If two distinct particle size populations were present at the time of a 
single measurement, the functions would show two decays. If population size was relatively 
uniform but changing over time, for instance during the time after heating, the functions would 
















0 min post heat
30 min post heat
60 min post heat














0 min post heat
30 min post heat
60 min post heat
5 days post heat





Figure 8: Autocorrelation functions at various times after removal from heat for samples heated (a) 10, (b) 15, (c) 
25, and (d) 29 minutes, respectively. 
 
As shown, the functions show near-identical decays, with the exception of some of the 
measurements taken immediately after removal from heat, likely an artifact of temperature 
gradient between the warm solution and room temperature instrument. This result lends one to 
conclude that not much aggregates during the studied period. This is confirmed by the derived 
particle size distributions, calculated as described previously. Figure 9 shows the averaged size 
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Figure 9: Hydrodynamic radii peak distributions and mean particle sizes for samples heated (a) 10, (b) 15, (c) 25, 
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The figures above show very little statistical difference in the time after heating, 
regardless of heat time, indicating that the majority of the population is still in monomeric form. 
However, the peak distributions are much clearly different after heating for all trials. The peaks 
exhibit broadening as a small fraction of the population becomes slightly larger, enough to skew 
the peak without generating a new distribution. This is thought to be the formation of dimers 
from monomers. The widths of the peaks are quantified and plotted below in Figure 10. 
 
Figure 10: Calculated hydrodynamic radius peak distribution widths versus time after removal from heat for 






















































































































The high standard deviations in Figure 6 are likely due to the fact that at any given time, 
particles are diffusing into and out of the laser light. The averages taken in order to form the 
above plots group measurements of 60 seconds across times as different as 8-10 minutes, 
meaning it is likely that many different particles are present for each measurement. Given the 
small amount of particles that are actually aggregating, this can have a substantial effect on the 
hydrodynamic radius calculation. 
The samples heated for 10 minutes show an average peak broadening that is not 
statistically significant. Samples heated for 15 minutes show a similar trend with slightly more 
statistical significance, and samples heated for 25 and 29 minutes show statistically significant 
broadening. Because the absolute peak width values can vary between samples, it is best to 
compare their changes after heating. Figure 11 shows the relative broadening after the samples 
were removed from heat. 
  
Figure 11: Peak broadening versus time after removal from heat for all samples 
 
In all samples, the broadening does not significantly decrease at any point after removal 
from heat. This indicates that the formed dimers do not return to monomers by thermal 





































also by the scattering intensity measurements from each sample. As previously mentioned, the 
scattering intensity is proportional to the size of the dissolved particles when concentration is 
kept constant. This assumption is valid for this system because since only a small amount of the 
particles are aggregating, the concentration can be assumed unchanged. The intensity 
measurements for the samples are shown below in Figure 12. 
 
 
Figure 12: Scattering intensity data versus time after removal from heat for samples heated (a) 10, (b) 15, (c) 25, 


































































































































 Like the peak width, in order to compare the samples it is best to look at the relative 
change in intensity versus time due to the variable nature of the absolute measurement. Figure 13 
shows the increase in intensity from the initial preheat baseline plotted against time after removal 
from heat. 
 
Figure 13: Intensity increase from preheat baseline versus time after removal from heat. 
 
Like the peak width, the intensity does not decrease over time after removal from heat, 
indicating that the cause of the intensity increase is still present. As previously mentioned, it is 
thought that the increase is caused by a small amount of dimer in solution. As expected, the 
samples display an intensity increase relative to the time spent on heat, i.e. the sample that was 











































Conclusions and Future Work 
 From the experiments performed in this study, it is clear that even just 10 minutes of 
heating produces aggregation that is irreversible by thermal quenching. The aggregation is most 
likely from monomer to dimer and only for a tiny portion of the particles in solution. Due to the 
nature of this aggregation, it is apparent that the studied realm is still in the slow initial realm of 
the sigmoidal aggregation curve. This is in contrast with the formation of larger aggregates that 
produce significant spikes in scattering intensity, which disappear after thermal quenching to 
room temperature. Proposed mechanisms of insulin aggregation suggest a slow and potentially 
reversible nucleation step. The initial step in the heat induced aggregation of insulin is shown to 
be different. 
 There is much potential for the continuation of this project. Of course, similar studies can 
be performed on insulin samples heated for shorter times; for instance 2, 5, 7, and 10 minutes. 
Because this heat times in this study were too long, despite the small amount of aggregation 
attained, shorter heat times will yield different and potentially more favorable reversibility 
results. However, according to the results of this study, it is likely that once any dimerization 
occurs, the formed aggregate is permanent, despite the shorter length of heating. 
 Additionally, the University of Connecticut Institute of Materials Science recently 
purchased a Bruker Small Angle X-Ray Scattering (SAXS) instrument. SAXS added capabilities 
over DLS, including the ability to distinguish morphology. Where DLS does not take into 
account shape when determining hydrodynamic radius, SAXS can actually produce information 
about particle shapes. This is particularly valuable for this study because the morphology of the 
insulin is changing as it aggregates. This analysis could yield critical information about the 
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